Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy

A secreted protein (Canopy 2, CNPY2) enhances angiogenesis and promotes smooth muscle cell migration and proliferation

(2015) Jian Guo et al.   CARDIOVASCULAR RESEARCH

Expression of CNPY2 in Mouse Tissues: Quantification and Localization

(2014) Kota Hatta et al.   PLoS One

Fibroblast Growth Factor-21 (FGF21) Regulates Low-density Lipoprotein Receptor (LDLR) Levels in Cells via the E3-ubiquitin Ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting Saposin-like Protein (Msap)

(2012) Hai Thi Do et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Multifarious molecular signaling cascades of cardiac hypertrophy: Can the muddy waters be cleared?☆

(2010) Pitchai Balakumar et al.   PHARMACOLOGICAL RESEARCH

Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies

(2010) Bianca C. Bernardo et al.   PHARMACOLOGY & THERAPEUTICS

Molecular Mechanisms Underlying the Transition of Cardiac Hypertrophy to Heart Failure

(2008) Toru Oka et al.   CIRCULATION JOURNAL